SCOPUS 정보 검색 플랫폼

Volumn 5, Issue 12, 2010, Pages S461-S462

Cell Cycle-Associated Kinases as Targets for Therapy in Lung Cancer

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; PROTEIN KINASE INHIBITOR;

ARTICLE; CELL CYCLE; CLINICAL TRIAL (TOPIC); DRUG ANTAGONISM; DRUG EFFECT; HUMAN; LUNG TUMOR; METABOLISM;

CELL CYCLE; CLINICAL TRIALS AS TOPIC; CYCLIN-DEPENDENT KINASES; HUMANS; LUNG NEOPLASMS; PROTEIN KINASE INHIBITORS;

EID: 79952465595 PISSN: 15560864 EISSN: 15561380 Source Type: Journal
DOI: 10.1097/01.JTO.0000391366.63882.30 Document Type: Article

Times cited : (10)

References (9)

1
- 22244478043
- Decoding the links between mitosis, cancer, and chemotherapy: the mitotic checkpoint, adaptation, and cell death
- Weaver, BA, Cleveland, DW, Decoding the links between mitosis, cancer, and chemotherapy: the mitotic checkpoint, adaptation, and cell death. Cancer Cell 8 (2005), 7–12.
- (2005) Cancer Cell , vol.8 , pp. 7-12
- Weaver, B.A.¹ Cleveland, D.W.²

2
- 25844475838
- On the road to cancer: aneuploidy and the mitotic checkpoint
- Kops, GJ, Weaver, BA, Cleveland, DW, On the road to cancer: aneuploidy and the mitotic checkpoint. Nat Rev Cancer 5 (2005), 773–785.
- (2005) Nat Rev Cancer , vol.5 , pp. 773-785
- Kops, G.J.¹ Weaver, B.A.² Cleveland, D.W.³

3
- 75149121482
- ARRY-520, a novel KSP inhibitor with potent activity in hematological and taxane-resistant tumor models
- Woessner, R, Tunquist, B, Lemieux, C, et al. ARRY-520, a novel KSP inhibitor with potent activity in hematological and taxane-resistant tumor models. Anticancer Res 29 (2009), 4373–4380.
- (2009) Anticancer Res , vol.29 , pp. 4373-4380
- Woessner, R.¹ Tunquist, B.² Lemieux, C.³

4
- 48449098623
- Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs
- Gascoigne, KE, Taylor, SS, Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs. Cancer Cell 14 (2008), 111–122.
- (2008) Cancer Cell , vol.14 , pp. 111-122
- Gascoigne, K.E.¹ Taylor, S.S.²

5
- 70349452101
- Evidence that mitotic exit is a better cancer therapeutic target than spindle assembly
- Huang, HC, Shi, J, Orth, JD, et al. Evidence that mitotic exit is a better cancer therapeutic target than spindle assembly. Cancer Cell 16 (2009), 347–358.
- (2009) Cancer Cell , vol.16 , pp. 347-358
- Huang, H.C.¹ Shi, J.² Orth, J.D.³

6
- 74549116355
- Targeting Polo-like kinase in cancer therapy
- Degenhardt, Y, Lampkin, T, Targeting Polo-like kinase in cancer therapy. Clin Cancer Res 16 (2010), 384–389.
- (2010) Clin Cancer Res , vol.16 , pp. 384-389
- Degenhardt, Y.¹ Lampkin, T.²

7
- 68549106081
- Kinesin motor proteins as targets for cancer therapy
- Huszar, D, Theoclitou, ME, Skolnik, J, et al. Kinesin motor proteins as targets for cancer therapy. Cancer Metastasis Rev 28 (2009), 197–208.
- (2009) Cancer Metastasis Rev , vol.28 , pp. 197-208
- Huszar, D.¹ Theoclitou, M.E.² Skolnik, J.³

8
- 41549122837
- Aurora kinases as anticancer drug targets
- Gautschi, O, Heighway, J, Mack, PC, et al. Aurora kinases as anticancer drug targets. Clin Cancer Res 14 (2008), 1639–1648.
- (2008) Clin Cancer Res , vol.14 , pp. 1639-1648
- Gautschi, O.¹ Heighway, J.² Mack, P.C.³

9
- 33747877023
- The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function
- Gizatullin, F, Yao, Y, Kung, V, et al. The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function. Cancer Res 66 (2006), 7668–7677.
- (2006) Cancer Res , vol.66 , pp. 7668-7677
- Gizatullin, F.¹ Yao, Y.² Kung, V.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.